SEC Form 4 · accession 0001203311-17-000086
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd E Simpson
Officer — Chief Financial Officer
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Nov 1, 2017 | S | 38,851 | $60.90 | D | 179,526 | D | |
| Common StockF3 | Nov 1, 2017 | S | 534 | $61.59 | D | 178,992 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2Table 1, Col 4, Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $60.51 to $61.35 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F3Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.